Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraosseous Vancomycin in Primary Total Hip Arthroplasty
NCT04042233Phase 4Completed
- Sponsor
- Houston Methodist Research Institute
- Start
- Dec 2019
- Primary completion
- May 2022
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in prosthetic joint infection (PJI), sponsored by Houston Methodist Research Institute. Started Dec 2019; status: completed.
02
Drugs
vancomycin
03
Conditions
prosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT04042233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04042233.